{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:28:37Z","timestamp":1792985317127,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.nmd.2023.10.020","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T22:48:44Z","timestamp":1699051724000},"page":"964-971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["The Dutch registry for facioscapulohumeral muscular dystrophy: Cohort profile and longitudinal patient reported outcomes"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6838-9345","authenticated-orcid":false,"given":"Joost","family":"Kools","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna CW","family":"Deenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M","family":"Blokhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 LM","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5837-7295","authenticated-orcid":false,"given":"Nicol C","family":"Voermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baziel GM","family":"van Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2023.10.020_bib0001","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.nmd.2017.09.007","article-title":"Early onset facioscapulohumeral dystrophy - a systematic review using individual patient data","volume":"27","author":"Goselink","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.10.020_bib0002","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1212\/CON.0000000000001155","article-title":"Facioscapulohumeral muscular dystrophy","volume":"28","author":"Mul","year":"2022","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.nmd.2023.10.020_bib0003","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1212\/WNL.0000000000000797","article-title":"Population-based incidence and prevalence of facioscapulohumeral dystrophy","volume":"83","author":"Deenen","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2023.10.020_bib0004","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/cjn.2015.311","article-title":"A systematic review and meta-analysis on the epidemiology of the muscular dystrophies","volume":"43","author":"Mah","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.nmd.2023.10.020_bib0005","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jval.2015.05.008","article-title":"Rare disease terminology and definitions-a systematic global review: report of the ispor rare disease special interest group","volume":"18","author":"Richter","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.nmd.2023.10.020_bib0006","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0000000000001008","article-title":"Both aerobic exercise and cognitive-behavioral therapy reduce chronic fatigue in FSHD: an RCT","volume":"83","author":"Voet","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2023.10.020_bib0007","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1212\/WNL.0000000000001783","volume":"85","author":"Tawil","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2023.10.020_bib0008","unstructured":"Efficacy and safety of losmapimod in treating patients with facioscapulohumeral muscular dystrophy (FSHD) (Reach), https:\/\/ClinicalTrials.gov\/show\/NCT05397470."},{"key":"10.1016\/j.nmd.2023.10.020_bib0009","unstructured":"Phase 1\/2 study of AOC 1020 in adults with facioscapulohumeral muscular dystrophy (FSHD), https:\/\/ClinicalTrials.gov\/show\/NCT05747924."},{"key":"10.1016\/j.nmd.2023.10.020_bib0010","unstructured":"A study to evaluate RO7204239 in participants with facioscapulohumeral muscular dystrophy, https:\/\/ClinicalTrials.gov\/show\/NCT05548556."},{"key":"10.1016\/j.nmd.2023.10.020_bib0011","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.nmd.2010.04.007","article-title":"171st ENMC international workshop: standards of care and management of facioscapulohumeral muscular dystrophy","volume":"20","author":"Tawil","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.10.020_bib0012","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.nmd.2017.04.004","article-title":"225th ENMC international workshop: a global FSHD registry framework, 18-20 November 2016, Heemskerk, The Netherlands","volume":"27","author":"Mul","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.10.020_bib0013","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.nmd.2021.07.013","article-title":"1st FSHD European Trial Network workshop: working towards trial readiness across Europe","volume":"31","author":"Voermans","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.10.020_bib0014","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0022-3999(94)90099-X","article-title":"Dimensional assessment of chronic fatigue syndrome","volume":"38","author":"Vercoulen","year":"1994","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.nmd.2023.10.020_bib0015","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/mus.24337","article-title":"The individualized neuromuscular quality of life questionnaire: cultural translation and psychometric validation for the Dutch population","volume":"51","author":"Seesing","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2023.10.020_bib0016","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0005-7967(97)00025-9","article-title":"Screening for major depression disorders in medical inpatients with the beck depression inventory for primary care","volume":"35","author":"Beck","year":"1997","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.nmd.2023.10.020_bib0017","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0304-3959(75)90044-5","article-title":"The McGill pain questionnaire: major properties and scoring methods","volume":"1","author":"Melzack","year":"1975","journal-title":"Pain"},{"key":"10.1016\/j.nmd.2023.10.020_bib0018","first-page":"669","article-title":"The Dutch version of the McGill pain questionnaire: a reliable pain questionnaire","volume":"139","author":"van der Kloot","year":"1995","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.nmd.2023.10.020_bib0019","unstructured":"Efficacy and safety of Losmapimod in subjects with facioscapulohumeral muscular dystrophy (FSHD), https:\/\/ClinicalTrials.gov\/show\/NCT04003974."},{"key":"10.1016\/j.nmd.2023.10.020_bib0020","unstructured":"Evaluation of safety, tolerability, and changes in biomarker and clinical outcome assessments of Losmapimod for FSHD1 with extension, https:\/\/ClinicalTrials.gov\/show\/NCT04004000."},{"key":"10.1016\/j.nmd.2023.10.020_bib0021","unstructured":"Castor EDC. Castor electronic data capture. 2019 [cited March 14, 2021]; Available from: https:\/\/castoredc.com."},{"key":"10.1016\/j.nmd.2023.10.020_bib0022","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1007\/s00415-021-10591-w","article-title":"The socioeconomic burden of facioscapulohumeral muscular dystrophy","volume":"268","author":"Blokhuis","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2023.10.020_bib0023","first-page":"1","article-title":"Facing facial weakness: psychosocial outcomes of facial weakness and reduced facial function in facioscapulohumeral muscular dystrophy","author":"van de Geest-Buit","year":"2022","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.nmd.2023.10.020_bib0024","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13023-018-0960-x","article-title":"The french national registry of patients with facioscapulohumeral muscular dystrophy","volume":"13","author":"Guien","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2023.10.020_bib0025","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00415-016-8132-1","article-title":"Design, set-up and utility of the UK facioscapulohumeral muscular dystrophy patient registry","volume":"263","author":"Evangelista","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2023.10.020_bib0026","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12874-021-01419-2","article-title":"Response rate of patient reported outcomes: the delivery method matters","volume":"21","author":"Neve","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.nmd.2023.10.020_bib0027","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1136\/jnnp.2004.050005","article-title":"Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I","volume":"76","author":"Kalkman","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2023.10.020_bib0028","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/mus.25991","article-title":"Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy","volume":"57","author":"Mor\u00eds","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2023.10.020_bib0029","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejpain.2005.06.009","article-title":"Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment","volume":"10","author":"Breivik","year":"2006","journal-title":"Eur J Pain"},{"key":"10.1016\/j.nmd.2023.10.020_bib0030","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0163-8343(98)00070-X","article-title":"Use of the beck depression inventory for primary care to screen for major depression disorders","volume":"21","author":"Steer","year":"1999","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.nmd.2023.10.020_bib0031","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pec.2010.08.021","article-title":"Course of normal and abnormal fatigue in patients with chronic obstructive pulmonary disease, and its relationship with domains of health status","volume":"85","author":"Peters","year":"2011","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.nmd.2023.10.020_bib0032","first-page":"1","article-title":"Defining minimal clinically important differences in pain and disability outcomes of patients with chronic pain treated with spinal cord stimulation","author":"Sabourin","year":"2021","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.nmd.2023.10.020_bib0033","article-title":"Validation of the individualized neuromuscular quality of life in Japanese patients with myotonic dystrophy","author":"Fujino","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2023.10.020_bib0034","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/ane.12788","article-title":"Prospective measurement of quality of life in myotonic dystrophy type 1","volume":"136","author":"Peric","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nmd.2023.10.020_bib0035","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.nmd.2013.01.008","article-title":"Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy","volume":"23","author":"Statland","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.10.020_bib0036","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00415-020-10144-7","article-title":"A 5-year clinical follow-up study from the Italian national registry for FSHD","volume":"268","author":"Vercelli","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2023.10.020_bib0037","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/mus.23529","article-title":"Patient-identified disease burden in facioscapulohumeral muscular dystrophy","volume":"46","author":"Johnson","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2023.10.020_bib0038","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1111\/ene.14863","article-title":"The facioscapulohumeral muscular dystrophy Rasch-built overall disability scale (FSHD-RODS)","volume":"28","author":"Mul","year":"2021","journal-title":"Eur J Neurol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623007733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623007733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:14:42Z","timestamp":1760775282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896623007733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0960896623007733"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2023.10.020","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Dutch registry for facioscapulohumeral muscular dystrophy: Cohort profile and longitudinal patient reported outcomes","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2023.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}